PubMed for id: 54584

Year	Number of Results
1999	1
2000	1
2001	2
2002	1
2004	3
2007	1
2008	3
2010	3
2011	1
2014	1
2015	3
2016	3
2017	3
2019	4
2020	2
2021	6
2022	3
2023	2
2024	1

1

FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways.

Huang M, Yao F, Nie L, Wang C, Su D, Zhang H, Li S, Tang M, Feng X, Yu B, Chen Z, Wang S, Yin L, Mou L, Hart T, Chen J. Huang M, et al. Mol Cell. 2023 Aug 3;83(15):2810-2828.e6. doi: 10.1016/j.molcel.2023.07.004. Mol Cell. 2023. PMID: 37541219

2

Sequencing of the coding regions of GNBIL on chromosome 22q11.2 as a risk gene of schizophrenia.

Wang YY, Hsu SH, Tsai HY, Cheng MC. Wang YY, et al. Psychiatry Res. 2021 Jun;300:113943. doi: 10.1016/j.psychres.2021.113943. Epub 2021 Apr 18. Psychiatry Res. 2021. PMID: 33932639

3

The schizophrenia/bipolar disorder candidate gene GNB1L is regulated in human temporal cortex by a cis-acting element located within the 3'-region.

Sun Y, Tao Y, Wang J, Saffen D. Sun Y, et al. Neurosci Bull. 2015 Feb;31(1):43-52. doi: 10.1007/s12264-014-1461-0. Epub 2014 May 15. Neurosci Bull. 2015. PMID: 24831436 Free PMC article.

4

Association study between GNB1L and three major mental disorders in Chinese Han populations.

Li Y, Zhao Q, Wang T, Liu J, Li J, Li T, Zeng Z, Feng G, He L, Shi Y. Li Y, et al. Psychiatry Res. 2011 May 30;187(3):457-9. doi: 10.1016/j.psychres.2010.04.019. Epub 2010 Jun 9. Psychiatry Res. 2011. PMID: 20538345

5

Supportive evidence for reduced expression of GNB1L in schizophrenia.

Ishiguro H, Koga M, Horiuchi Y, Noguchi E, Morikawa M, Suzuki Y, Arai M, Niizato K, Iritani S, Itokawa M, Inada T, Iwata N, Ozaki N, Ujike H, Kunugi H, Sasaki T, Takahashi M, Watanabe Y, Someya T, Kakita A, Takahashi H, Nawa H, Arinami T. Ishiguro H, et al. Schizophr Bull. 2010 Jul;36(4):756-65. doi: 10.1093/schbul/sbn160. Epub 2008 Nov 14. Schizophr Bull. 2010. PMID: 19011233 Free PMC article.

6

Strong evidence that GNB1L is associated with schizophrenia.

Williams NM, Glaser B, Norton N, Williams H, Pierce T, Moskvina V, Monks S, Del Favero J, Goossens D, Rujescu D, Giegling I, Kirov G, Craddock N, Murphy KC, O'Donovan MC, Owen MJ. Williams NM, et al. Hum Mol Genet. 2008 Feb 15;17(4):555-66. doi: 10.1093/hmg/ddm330. Epub 2007 Nov 13. Hum Mol Genet. 2008. PMID: 18003636

7

β-blocker therapy and heart rate control during exercise testing in the general population: role of a common G-protein β-3 subunit variant.

Dörr M, Schmidt CO, Spielhagen T, Bornhorst A, Hentschel K, Franz C, Empen K, Kocher T, Diehl SR, Kroemer HK, Völzke H, Ewert R, Felix SB, Rosskopf D. Dörr M, et al. Pharmacogenomics. 2010 Sep;11(9):1209-21. doi: 10.2217/pgs.10.88. Pharmacogenomics. 2010. PMID: 20860462 Free PMC article.

8

Isolation and characterization of a novel gene containing WD40 repeats from the region deleted in velo-cardio-facial/DiGeorge syndrome on chromosome 22q11.

Funke B, Pandita RK, Morrow BE. Funke B, et al. Genomics. 2001 May 1;73(3):264-71. doi: 10.1006/geno.2000.6506. Genomics. 2001. PMID: 11350118

9

GNB1L, a gene deleted in the critical region for DiGeorge syndrome on 22q11, encodes a G-protein beta-subunit-like polypeptide.

Gong L, Liu M, Jen J, Yeh ET. Gong L, et al. Biochim Biophys Acta. 2000 Nov 15;1494(1-2):185-8. doi: 10.1016/s0167-4781(00)00189-5. Biochim Biophys Acta. 2000. PMID: 11072084

10

GbetaL regulates TNFalpha-induced NF-kappaB signaling by directly inhibiting the activation of IkappaB kinase.

Kim YL, Kim JE, Shin KJ, Lee S, Ahn C, Chung J, Kim DH, Seong JY, Hwang JI. Kim YL, et al. Cell Signal. 2008 Nov;20(11):2127-33. doi: 10.1016/j.cellsig.2008.08.001. Epub 2008 Aug 9. Cell Signal. 2008. PMID: 18755269

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

38 results

Results by year